MML Investors Services’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
MML Investors Services's BBH Position: Q1 2026 in Review
MML Investors Services sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 2,027 shares — an estimated $384K sold.
MML Investors Services first reported a position in BBH in Q2 2017 and held it in 15 quarters. The position peaked at $743K in Q1 2023. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- MML Investors Services reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
- MML Investors Services sold 2,027 VanEck Biotech ETF shares in Q1 2026, an estimated $384K.
- MML Investors Services first reported a position in VanEck Biotech ETF in Q2 2017 and held it in 15 quarters.
- MML Investors Services's VanEck Biotech ETF position peaked at $743K in Q1 2023.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.